(Q36512832)

14 August 2017

Ten common questions (and their answers) about off-label drug use. (English)

1 reference

14 August 2017

2

Christopher M Burkle

1 reference

14 August 2017

Christopher M Wittich

series ordinal

1

1 reference

14 August 2017

William L Lanier

series ordinal

3

1 reference

14 August 2017

language of work or name

English

0 references

publication date

6 August 2012

1 reference

14 August 2017

1 reference

14 August 2017

87

1 reference

14 August 2017

10

1 reference

14 August 2017

982-990

1 reference

Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538391

Abhorring the vacuum: use of Alzheimer’s disease medications in frontotemporal dementia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538391

Dabigatran etexilate: a novel oral thrombin inhibitor for thromboembolic disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538391

Strategies and practices in off-label marketing of pharmaceuticals: a retrospective analysis of whistleblower complaints

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538391

Off-label use of azathioprine in dermatology: a systematic review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538391

The ClinicalTrials.gov results database--update and key issues

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538391

Increasing off-label use of antipsychotic medications in the United States, 1995-2008

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538391

Erythromycin as a prokinetic agent: risk factors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538391

Recommendations for the pharmacological management of neuropathic pain: an overview and literature update

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538391

Off-label prescribing: a call for heightened professional and government oversight

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538391

Shifting terrain in the regulation of off-label promotion of pharmaceuticals

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538391

Informed consent and shared decision-making: a requirement to disclose to patients off-label prescriptions

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538391

Update on pharmacotherapy guidelines for the treatment of neuropathic pain

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538391

Regulating off-label drug use--rethinking the role of the FDA.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538391

Time to nip "seeding trials" in the bud.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538391

Off-label uses of biologic agents in dermatology: a 2006 update

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538391

Trends in off-label beta-blocker use: a secondary data analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538391

Off-label prescribing among office-based physicians

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538391

Off-label applications for SSRIs.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538391

Consensus guidelines for managing postoperative nausea and vomiting

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538391

Social phobia. Review of a neglected anxiety disorder

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538391

Treatment options for female sexual arousal disorder: part II.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538391

Off-label drug use in hospitalized children.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538391

Did the removal of the indication of nocturnal enuresis for intranasal desmopressin change prescribing practice?

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538391

Pediatric antidepressant medication errors in a national error reporting database

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538391

Eli Lilly pays record $1.4bn for promoting off-label use of olanzapine

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538391

Physicians' liability for off-label prescriptions.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538391

Isoflurane therapy for severe refractory status asthmaticus in children

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538391

Off-label prescribing of drugs in specialty headache practice.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538391

The birth of opioid anesthesia

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538391

Off-label and unlicensed medication use and associated adverse drug events in a pediatric emergency department

21 September 2018

1 reference

12 December 2020

Off-label medication use in adult critical care patients

1 reference

12 December 2020

Enforcement actions involving Medicaid fraud and abuse, 1996-2009

1 reference

12 December 2020

Uses of drugs not described in the package insert (off-label uses)

1 reference

12 December 2020

Pharmacologic closure of patent ductus arteriosus in the premature infant

1 reference

12 December 2020

From the Food and Drug Administration

1 reference

12 December 2020

Off-label use of antidepressant, anticonvulsant, and antipsychotic medications among Georgia medicaid enrollees in 2001

1 reference

12 December 2020

Orphan Drug Act passes quarter-century milestone in fight against rare diseases

1 reference

12 December 2020

FDA allows drug firms to distribute journal articles about unapproved uses

1 reference

12 December 2020

Pfizer settles largest ever fraud suit for off-label promotion

1 reference

12 December 2020

Abbott pays $1.6bn for promoting off label use of valproic acid

1 reference

12 December 2020

10.1016/J.MAYOCP.2012.04.017

Identifiers

DOI

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

22877654

1 reference